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It is well known that catecholamines significantly modify the sympathetic ganglionic transmission (1-10). Since Eccles and Libet (7) proposed a model of ganglionic transmis sion characterized by adrenergically mediated hyperpolarizing potentials, many reports have appeared concerning the action and the physiologic role of catecholamines in sympa thetic ganglia. De Groat and Volle (9) have investigated the effect of catecholamines on the transmission in the superior cervical ganglion of the cat, and they postulated two phar macologically distinctive adrenoceptive sites in sympathetic ganglia, &alpha;-and &beta;-receptors responding to the drugs with depression and facilitation, respectively. According to this concept, the enhancement of ganglionic transmission by small doses of epinephrine and norepinephrine (3, 6) might be attributed to the activation of adrenergic ganglionic &beta;-receptor, however, findings are not consistent with those of others who failed to demonstrate such an enhancement (1, 4, 5). Thus, reports on the catecholamine effects on sympathetic ganglia are still in dispute.<BR>
The action of catecholamines on sympathetic ganglia has been studied mostly on the superior cervical ganglion, with only a few studies on the stellate ganglion (4, 5) . In our preliminary studies on the efferent discharge of cardiac sympathetic nerve, a depressant action of epinephrine was demonstrated on the stellate ganglion. The finding led us to a further investigation of the effect of catecholamines on this ganglion. In the present experiment, changes in the amplitude of sympathetic evoked action potentials were observed in postganglionic fibers of the stellate ganglion. It is evident that most sympathetic nerves towards the heart synapse with the stellate ganglion. In order to examine the physiologic role of catecholamines in sympathetic activities in cardiovascular system, changes in intra ventricular pressure caused by the preganglionic nerve stimulation were monitored during topical application of catecholamine to the ganglion.
METHODS
Forty-seven cats of both sexes were anesthetized by intraperitoneal injection of sodium pentobarbitone (30 mg/kg). Cats were ventilated with a positive pressure respirator through a tracheal cannula. The chest was widely opened in a midline incision, and the left stellate ganglion exposed. All nerve fibers connected to the ganglion were cut and crushed, except for the third or fourth ramus with thoracic sympathetic nerve trunk and the cardiac nerve, which were dissected free from the surrounding connective tissue.
In forty cats, in order to examine the effect of catecholamines on sympathetic evoked action potentials in the stellate ganglion, a suitable length of the cardiac nerve was cut peri pheral to the ganglion. The third or fourth ramus with thoracic sympathetic nerve trunk was placed on a pair of electrodes and stimulated electrically. Sympathetic evoked action potentials were recorded at the central cut end of the cardiac nerve suspended in mineral oil on a pair of Ag-AgCI electrodes connected to a c.r.-coupled amplifier having a time constant of 2.0 sec. Amplified action potentials were monitored on a dual beam cathode ray oscilloscope (Nihonkohden VC-7), and were photographed (Nihonkohden WC-1B).
In seven cats a 1/5 gauge needle was inserted into the left subclavian artery supplying the stellate ganglion for local administration of the drug to the ganglion. In five cats, reser pine (0.8 mg/kg) was injected intramuscularly 24 hr prior to the experiment. In seven cats, effects of preganglionic nerve stimulation on intraventricular pressure were observed during topical application of norepinephrine to the left stellate ganglion. As an anticoagulant, heparin sodium (5,000 U/ kg) was injected intravenously. A piece of cotton immersed with 0.1 ; norepinephrine solution was put on the ganglion. Intra ventricular pressure was recorded using an electronic manometer (Nihonkohden MT-4T) through a polyethylene tube connected to a 1.0 gauge needle inserted into the left ventricle.
Drugs employed include I-epinephrine hydrochloride, dl-norepinephrine hydrochloride, dl-isoproterenol hydrochloride, dopamine hydrochloride, tyramine hydrochloride, pheny lephrine hydrochloride, methoxamine hydrochloride, tetraethylammonium bromide and reserpine. The doses were presented in terms of mg or 1g/kg of the salts.
All experiments were carried out under room temperature of 24-28-C.
RESULTS
Compound action potentials evoked by the preganglionic nerve stimulation Fig. I shows action potentials in the cardiac nerve evoked by electrical preganglionic stimulation with a duration of 0.1 cosec and a strength of 2V. When the strength of the stimulation gradually increased, potential changes with three phases were observed. The first wave of compound action potentials appeared with delay of 2.5-5 msec, the second, 10-25 msec, and the last, 25-70 cosec. Distance between stimulating electrodes and record ing electrodes was about 50 mm. This result may suggest that the first component falls into the category of the action potential arising in A fiber, the second, in B fiber, and the last, in sC fiber (11) . The appearence of A and B waves indicates the presence of fibers passing through the stellate ganglion without synaptic connection (12) .
Effects of catecholamines on evoked postganglionic action potentials failed to be demonstrated even when lower doses than 5 1tg/kg of epinephrine or nore pinephrine were used. The amplitude of sC potentials was markedly reduced by a large dose of epinephrine (0.2 mg/kg), but never completely abolished (Fig. 3) .
Under the same experimental conditions as the case of epinephrine, the intravenous injection of isoproterenol (2 /zg/kg) produced an increase of the amplitude of sC potentials (Fig. 4) . Amplitude began to increase 10 sec after injection of isoproterenol, reached 130 Dopamine, in a dose of 10,ug/kg, did not alter the amplitude of sC potentials, while in doses more than 0.1 mg/kg it depressed the amplitude and caused a marked rise in systemic blood pressure. Evoked action potentials decreased to 90% of the initial level 20 sec after injection, reached the minimum level of 80 % and returned to the initial level within 70 sec. Fig. 5 shows the rate of changes in sC potentials to the initial level after the adminis tration of epinephrine, norepinephrine, isoproterenol and dopamine.
Effects of adrenergic cti and 8-receptor blockades
The interaction between catecholamines and adrenergic receptor blockades was ex amined on evoked sC potentials. During the suprathreshold stimulation, the injection of an ce-receptor blocking agent, phentolamine (2 mg/kg), did not induce any change in evoked action potentials. When norepinephrine (5 pg/kg) or epinephrine (5 ug/kg) was adminis tered 2 min after injection of phentolamine, there was neither inhibition nor enhancement of the amplitude of sC potentials (Fig. 6) . These results indicate that the adrenergic a receptor blockade itself has no influence on evoked action potentials, but does block the inhibitory effect due to norepinephrine or epinephrine.
The injection of a 9-receptor blocking agent, propranolol (0.2 mg/kg), produced no appreciable alteration in evoked action potentials. Isoproterenol (2 pg/kg) administered 2 min after injection of propranolol produced neither inhibition nor enhancement of the amplitude of sC potentials (Fig. 6) . The result indicates that the adrenergic a-receptor blockade annuls the isoproterenol-induced enhancement of the amplitude of evoked action 
Effects of tyramine
Tyramine was used for studying the significance of endogenous catecholamines on the ganglionic transmission. When 0.5 mg/kg was given intravenously, it was observed that sC potentials decreased to 75 % of the initial level after 20-30 sec, reaching 60 % after 40 50 sec. The amplitude gradually increased to return to 65-70 % about 2 min later and remained at this level for more than 10 min (Fig. 7) . Tyramine (0.1 mg 0.1 ml) was injected into the left subclavian artery supplying the stellate ganglion. A depression of the amplitude of sC potentials occurred within 5 sec, and the amplitude returned to the initial level about 40 sec later (Fig. 7) .
In five cats given reserpine (0.8 m-'kg) intramuscularly 24 hr prior to the experiment, systemic and local application of tyramine did not cause any inhibitory action on evoked sC potentials.
Effects of asphyxia and rasoconstr-ictor.s In order to clarify whether the reduction of evoked action potentials in the sympathetic ganglion was caused by ganglionic ischemia, effects of asphyxia and some vasoconstrictors on sC potentials were examined. Asphyxia was produced by interrupting the positive pressure respirator for 7 min.
The amplitude of sC potentials began to increase about 60 sec after the onset of asphyxia, reached 160 of the initial level at 90 sec, and then gradually decreased to return to the initial level after about 5 min (Fig. 8) .
Ganglionic ischernia was induced by phenylephrine (0.1 mg/kg) or methoxamine (0.1 mg/kg). When injected intravenously during the suprathreshold stimulation, methoxamine did not produce any change in the amplitude of evoked action potentials, while phenylephrine caused a slight inhibition of sC potentials (Fig. 8) .
A ganglionic blocking agent, tetraethylammonium bromide (5 mg/kg), induced a marked depression of the amplitude of sC potentials 15 sec after injection, and completely As reported on the superi or cervical ganglion (1, 3, 6, 7. 9), epinephrine, norepinephrine and dopamine injected intravenously also reduced sympathetic evoked action potentials in the stellate ganglion, while isoproterenol increased the potentials. These results indicate that adrenergic ;i and preceptor stimulants have inhibitory and facilitatorv LfTects on (lie ,tellate ganglion, respectively. l)e Groat and Vollc (9) hypothesized two pharm tcologically distinctive adrenoceptive sites in the superior cervical ganglion of the cat. One site which was blocked by ii-receptor blockade meditated catecholamine-induced ganglionic inhibition.
The other site blocked by ,i-receptor blockade mediated catecholamine-induced ganglionic facilitation. When epinephrine is administered after application of (t-receptor blockade, enhancement of the amplitude of evoked action potentials could he ohseryed. In the present experiment the adrener_gic re-receptor blockade blocked the inhibitory effect caused by epinephrine or norepinephrine, but such an enhancement as observed in the superior cervical ganglion did not appear in the stellate ganglion. This may suggest that an adrenergic ,7-receptor in the stellate ganglion responds to epinephrine less sensitively than in the superior cervical ganglion.
13u1bring (3) and Trendelenhurg (6) It is clear that asphyxia induces the rele•rse of catecholamines from the adrenal medulla and sympathetic nerve endings, following which asphyxia should depress the ganglionie transmission. In the present experimentr augmentation of post ganglionic potentials was
Observed. It has been reported that asphyxiation produced a fall in the critical firing level as well as a slight depolarization in nerve fibers (14, 15) . Therefore, the above augmentation may he explained by decreased threshold of depolarization in the gan glion cells.
A vasoconstrictor, metho.xamine, did not produce any change in the amplitude of evoked action potentials. It was thought unlikely that catecholamine-induced ganglionie inhibition was due to ischemia. Phenylephrine caused a slight depression of' SC potentials.
This depression may he attributed to the ; i-receptor stimulating action of phenylephrinc itself.
Depression of the ganglionic transmission observed after intravenous injection of t -yra mine is explained by the release of catecholamines from chromafiin cells. This plan sihility is supported by the fact that the depression was not ohseryed in animals pretreated with reserpine. The local application of tyramine to the stellate ganglion also inhibited the ganglionic transmission, and the pretreatment with reserpine blocked the inhibition. 
SUMMARY
Effects of catecholamines on sympathetic evoked action potentials were investigated electrophysiologically in the stellate ganglion of anesthetized cats. Sympathetic action potentials evoked in the cardiac nerve by electrical stimulation of preganglionic fibers con tained three components: an A elevation, a B elevation and mostly a sC elevation.
Epinephrine, norepinephrine and dopamine had an inhibitory effect on evoked potentials in the ganglion. Epinephrine depressed the ganglionic transmission, regardless of (lose employed. These actions were blocked by an adrenergic (i-receptor blockade. Although epinephrine was adminstered after the injection of (e.-receptor blockade, enhancement of the amplitude of sC potenitials was not observed. Isoproterenol augmented the ganglionic transmission, and this action was blocked by ;-f-receptor blockade. Methoxamine had no effect on evoked potentials. Phenylephrine caused a slight inhibition on the transmission. Asphyxia produced the augmentation of sC potentials. Systemic and local application of tyramine caused depression on the transmission by inducing the release of endogenous catecholamines. These effects were blocked by reserpine given previously. The pregan glionic nerve stimulation in the stellate ganglion produced a rise in left intraventricular pressure and an increase in dP/dt. These responses were depressed by topical application of norepinephrine to the stellate ganglion. It is considered that endogenous catechol amines . epinephrine, norepinephrine and dopamine, which are released from the adrenal medulla and sympathetic nerve endings, depress the transmission in the stellate ganglion, thus exerting humoral autoregulation of cardiovascular activity.
